← Back to companies
Bicara Therapeutics
0 open4 filled
Cambridge, Massachusetts, United StatesFounded 202058+ employeesGrowth raisedGrowthBCAX
Last round: post ipo equity · $150M · Feb 2026(4 rounds total)
Founded by Claire Mazumdar
Backed by(19 investors)
The Rise FundBraidwellRA Capital ManagementBioconRed Tree Venture CapitalTPGF-PrimeJanus Henderson InvestorsPremji InvestPiper Heartland Healthcare CapitalBioqube VenturesOmega FundsEight Roads VenturesDeerfield Management
Bicara Therapeutics is a clinical-stage company developing first-in-class biologics engineered to bring together the precision of targeted therapy and the power of tumor modulators. The company's dual-action biologics are designed to deliver an immunomodulatory payload directly to the tumor microenvironment to ramp up immune cell activity, potentially offering long-lasting efficacy. For more, please visit: bicara.com.
Open Positions at Bicara Therapeutics (0 Jobs)
No open positions at the moment.
Browse All JobsReady to start your space career at Bicara Therapeutics?
